CHOP Research Institute

Center for Applied Genomics

Today's Research Becomes Tomorrows Cure

CAG Leads First Large-Scale Genetic Study of Migraine in Children and in African-Americans.
Article by: Eureka Alert; October 11, 2018
 

CAG researchers have identified a gene mutation that causes a serious lymphatic condition, and used that knowledge to restore normal lymphatic vessels in model animals. The laboratory findings may lead to a new therapy for patients with this type of abnormal lymphatic circulation.
MedicalXpress; August 28, 2018
 

Using Edico Genome’s DRAGEN pipeline on 1,000 Amazon EC2 F1 instances, the Children’s Hospital of Philadelphia (CHOP) and Edico Genome set a new scientific world standard last week in rapidly processing whole human genomes. CHOP used the DRAGEN pipeline to process 1,000 whole pediatric genomes in two hours and twenty-five minutes.
Facebook-Hosted Panel Discussion; March 27, 2018
 

Using Edico Genome’s DRAGEN pipeline on 1,000 Amazon EC2 F1 instances, the Children’s Hospital of Philadelphia (CHOP) and Edico Genome set a new scientific world standard last week in rapidly processing whole human genomes. CHOP used the DRAGEN pipeline to process 1,000 whole pediatric genomes in two hours and twenty-five minutes.
Article by: Bio-IT World; October 23, 2017
 

Pediatric researchers in the Roberts Collaborative for Genetics and Individualized Medicine at Children's Hospital of Philadelphia have identified common gene variants that raise the risk of developing an aggressive form of the childhood cancer neuroblastoma. The discovery may assist doctors in better diagnosing subtypes of neuroblastoma.
Article by: EurekaAlert!; September 25, 2017
 

The Center for Data Driven Discovery in Biomedicine at Children's Hospital of Philadelphia (CHOP) will lead a new, collaborative effort funded by the National Institutes of Health Common Fund to discover the causes of pediatric cancer and structural birth defects through the use of big data. The Center will be known as the "Kids First Pediatric Data Resource Center" (DRC).
Article by: EurekaAlert!; August 15, 2017
 

Aevi Genomic Medicine reports a trial investigating a personalized drug for attention deficit hyperactivity disorder.
Article by: GenomeWeb; April 21, 2017
 

Three scientists at Children’s Hospital of Philadelphia who identified and studied a genetic disease have been recognized by having their names attached to the disorder.
Article by: Science Daily; March 27, 2017
 

Medgenics focuses on genomic medicine with a partnership with Center for Applied Genomics at The Children's Hospital of Philadelphia (CHOP).
Article by: SeekingAlpha; October 27, 2016
 

Researchers have discovered a gene region that raises the risk a child will have a middle ear infection, known to doctors as acute otitis media (AOM) -- and known to parents as one reason for a screaming, unhappy preschooler. The finding may offer an early clue to helping doctors develop more effective treatments to prevent one of the most common childhood illnesses.
Article by: ScienceDaily; October 06, 2016